-The Hindu Business Line Experts say authorities will need to probe and take quick action, in the interest of keeping the faith in medicine exports from India The death of 66 children in Gambia, potentially-linked to four cough and cold syrups made in India by Maiden Pharmaceuticals, has brought up the quality question, again. How did an allegedly contaminated product slip through the regulatory cracks, casting a long shadow on the Indian...
More »SEARCH RESULT
Total Matching Records found : 314
Maiden pharma, under WHO scanner for Gambia kids' deaths, flouted norms in 4 states -Milan Sharma
-IndiaToday.in The Central Drugs Standard Control Organisation (CDSCO) has not yet barred the company from operations in India even as many of its medical products made for Indian use have also been found to be of substandard quality, often flagged by authorities. Ever since Maiden Pharmaceuticals has come under the scanner of the World Health Organisation (WHO) after being flagged for the four cough syrups manufactured in India and exported to Gambia...
More »Healthcare Continues to Remain Inaccessible for Dalits and Adivasis, Says Study
-Newsclick.in The high healthcare costs were expected to be addressed through the introduction of health insurance by the Union government, but it covers less than 30% of hospital charges leaving a heavy financial burden on the poor. Health outcomes have remained grossly unequal, with India's dalits and adivasis living shorter lives of poorer quality, as per a recent paper published by Oxfam India. Private infrastructure now accounts for nearly 62% of India's...
More »Is the govt. doing enough for the Jan Aushadhi scheme?
On Janaushadhi Diwas this year (i.e., March 7th, 2022), Prime Minister Shri Narendra Modi stated that the poor and the middle-class benefited from the 'Jan Aushadhi Kendras' that were set up to provide generic drugs at affordable prices. He said that the poor and the middle class saved around Rs.13,000 crore through these stores during the COVID-19 pandemic. In the wake of COVID 19 crisis, the 'Bureau of Pharma PSUs of India'...
More »Poor, Middle Class Benefitted From The 'Jan Aushadhi Kendras': PM Modi
-PTI/ NDTV.com The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) is a campaign launched by the Department of Pharmaceuticals to provide quality medicines at affordable prices to the masses New Delhi: Prime Minister Narendra Modi said the poor and the middle class have benefitted from the 'Jan Aushadhi Kendras', set up to provide generic drugs at affordable prices, and they saved about ₹ 13,000 crore through the stores. He also interacted with 'Jan Aushadhi...
More »
